To guide public health and vaccination strategies, researchers assessed a variety of factors regarding community-acquired pneumonia and its causes.
|Articles|November 25, 2022
News Roundup: November 21 to November 25
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
How Drug Shortages Are Prevented by the FDA
With supply chain issues impacting many industries, drug shortages have occurred. How does the FDA address them?
Research Examines Link Between Vitiligo and Systemic Sclerosis
Israeli researchers find more than fivefold risk of developing systemic sclerosis among people with vitiligo.
Flash Glucose Monitoring May Prompt Lifestyle Changes in Prediabetes
New research indicates that glucose monitoring could lead to lifestyle changes during prediabetes.
Examining Treatment Options for Rosacea and Acne
Addressing the 2 inflammatory conditions requires careful consideration of the therapies to use.
Accelerated Approval to Mirvetuximab Soravtansine-gynx Granted by FDA
This is the first FDA-approved ADC for platinum-resistant disease, according to ImmunoGen.
Advertisement
Related to this article
Highlighting the clinical impact of the pharmacy profession, we caught up with pharmacists of various types to get their perspectives on the evolution of pharmacy.
A newly erected Women’s Health Division within NIH will work in tandem with the Office of Research on Women’s Health.
Rita King, CEO of MethodSense, provides her expertise on the integration of AI in medical devices and key developments for pharmacists as the technology evolves.
Harini Bupathi, Esq, explains why pharmacies need to continue prioritizing PBM relationships despite rapid legislative change.
Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.
Brianne Porter, PharmD, MS, explores how pharmacists can deliver care to a population of women experiencing life-altering symptoms of urinary incontinence.
AJ Barbarito, Esq, explains how ERISA and Medicare Part D preemption limit state PBM laws and why a private right of action may be the most effective path forward.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use
2
American Pharmacists Month: The Importance of Pharmacy-PBM Relationships
3
Q&A: Why Enforcement Is the Weak Link in State PBM Reform | NCPA 2026
4
FDA Approves Bepirovirsen Injection to Treat Chronic Hepatitis B
5